BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ARMI - ECPv6.18.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.armiusa.org
X-WR-CALDESC:Events for ARMI
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261202
DTEND;VALUE=DATE:20261204
DTSTAMP:20261030T141401Z
CREATED:20261030T141401Z
LAST-MODIFIED:20261030T141401Z
UID:10001817-1796169600-1796342399@www.armiusa.org
SUMMARY:NIH-HESI Workshop: Assessing Emerging Cell and Gene Therapies for Disease-Specific Therapeutic Applications
DESCRIPTION:ARMI | BioFabUSA will participate in the upcoming National Institutes of Health (NIH) and Health and Environmental Sciences Institute (HESI) workshop\, Assessing Emerging Cell and Gene Therapies for Disease-Specific Therapeutic Applications: In Vivo Tracking and Biodistribution. \nDr. Richard McFarland\, ARMI’s Chief Regulatory Officer\, will serve as a panel moderator\, contributing to discussions focused on advancing scientific understanding\, cross-sector collaboration\, and the development of cell and gene therapies. \nThis two-day workshop brings together experts from government\, academia\, industry\, and other stakeholder organizations to examine the current state of in vivo tracking and biodistribution technologies across preclinical and clinical applications. \nWorkshop Highlights\nTopics will include: \n\nCurrent approaches to tracking the localization\, persistence\, and fate of cell and gene therapies.\nTechnical challenges and emerging imaging technologies.\nRegulatory and public health considerations.\nOpportunities to strengthen translation from preclinical research to clinical applications.\nFuture research priorities\, funding opportunities\, and industry-government-academic collaboration.\n\nThe workshop will feature presentations\, panel discussions\, and breakout sessions designed to identify scientific and technical gaps and opportunities to advance cell and gene therapy development. \nRegistration: Learn More & Register \nOrganizer: National Institutes of Health (NIH) and Health and Environmental Sciences Institute (HESI Global).
URL:https://www.armiusa.org/event/nih-hesi-workshop-assessing-emerging-cell-and-gene-therapies-for-disease-specific-therapeutic-applications/
LOCATION:Hybrid
CATEGORIES:ARMI,BioFabUSA
ATTACH;FMTTYPE=image/png:https://www.armiusa.org/wp-content/uploads/2022/05/PartnerLive-e1653358779467.png
END:VEVENT
END:VCALENDAR